Abstract
Resistance ofHelicobacter pylori to Clarithromycin is due to point mutations at position A2143 or A2144 of therrnH 23S rRNA gene, each mutation creating an additional restriction site for Bsal orMboII. A procedure combining PCR and RFLP analysis was evaluated for detection of these mutations using primers specific for the 23S rRNA gene, andBsaI andMboII enzymes. All clarithromycin-resistant isolates (8/8), as defined by the MIC, were found to be resistant by PCR-RFLR No clarithromycin-sensitive isolates (14/14) gave a positive reaction.
Similar content being viewed by others
References
Tursi A, Cammarota G, Papa A, Montalto M, Fedeli G, Gasbarrini G: Short-term low-dose triple therapy with lansoprazole plus amoxicillin and clarithromycin forHelicobacter pylori eradication. American Journal of Gastroenterology 1996, 91: 1668–1670.
Cayla R, Zerbib F, Talbi P, Mégraud F, Lamouliatte H: Pre- and post-treatment clarithromycin resistance ofHelicobacter pylori strains: a key factor of treatment failure. Gut 1995, 37, Supplement 1: A55.
Mégraud F:Helicobacter pylori resistance to antibiotics. In: Hunt RH, Tytgat GNJ (ed):Helicobacter pylori: basic mechanisms to clinical cure. Kluwer, Dordrecht, 1993, p. 570–583.
Godard AF, Logan RPH: Antimicrobial resistance andHelicobacter pylori. Journal of Antimicrobial Chemotherapy 1996, 37: 639–643.
European Study Group on Antibiotic Susceptibility ofHelicobacter pylori: Results of a multicentre European survey in 1991 of metronidazole resistance inHelicobacter pylori. European Journal of Clinical Microbiology & Infectious Diseases 1992, 9: 777–781.
Henriksen TH, Brorson Ö, Schöyen R, Thoresen T: Risks related to lack of standardization of tests to detect in vitro metronidazole resistance inHelicobacter pylori. European Journal of Clinical Microbiology & Infectious Diseases 1996, 15: 484–488.
Ettayebi M, Prasad SM, Morgan EA: Chloramphenicol-erythromycin resistance mutations in a 23S rRNA gene ofEscherichia coli. Journal of Bacteriology 1985, 162: 551–557.
Meier A, Kirschner P, Springer B, Steingrube VA, Brown BA, Wallace RJ, Bottger EC: Identification of mutations in 23S rRNA gene of clarithromycin resistantMycobacterium intracellulare. Antimicrobial Agents and Chemotherapy 1994, 38: 381–384.
Weisblum B: Erythromycin resistance by ribosome modification. Antimicrobial Agents and Chemotherapy 1995, 39: 577–585.
Skinner R, Cundiffe E, Schmidt FJ: Site of action of a ribosomal RNA methylase responsible for resistance to erythromycin and other antibiotics. Journal of Biological Chemistry 1983, 258: 12702–12706.
Versalovic J, Shortridge D, Kibler K, Griffy M, Beyer J, Flamm RK, Tanaka K, Graham DY, Go MF: Mutations in 23S rRNA are associated with clarithromycin resistance inHelicobacter pylori. Antimicrobial Agents and Chemotherapy 1996, 40: 477–480.
National Committee for Clinical Laboratory Standards: Methods for antimicrobial susceptibility testing of anaerobic bacteria. Approved Standard M11-A2. NCCLS, Villanova, PA, 1990.
Hachem CY, Clarridge JE, Reddy R, Flamm R, Evans DG, Tanaka SK: Antimicrobial susceptibility testingHelicobacter pylori. Comparison of E test, broth microdilution, and disk diffusion for ampicillin, clarithromycin, and metronidazole. Diagnostic Microbiology and Infectious Diseases 1996, 24: 570–583.
Xia HX, Buckley M, Keane CT, O'Morain CA: Clarithromycin resistance inHelicobacter pylori: prevalence in untreated dyspeptic patients and stability in vitro. Journal of Antimicrobial Chemotherapy 1996, 37: 473–481.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Szczebara, F., Dhaenens, L., Vincent, P. et al. Evaluation of rapid molecular methods for detection of clarithromycin resistance inHelicobacter pylori . Eur. J. Clin. Microbiol. Infect. Dis. 16, 162–164 (1997). https://doi.org/10.1007/BF01709478
Issue Date:
DOI: https://doi.org/10.1007/BF01709478